Accelerate Diagnostics Stock Price

1.31 (12.6%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Accelerate Diagnostics Inc AXDX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
1.31 12.6% 11.71 20:00:00
Close Price Low Price High Price Open Price Previous Close
11.50 10.37 11.65 10.37 10.40
Bid Price Ask Price Spread News
9.90 12.00 2.10 - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
2,996 365,394 $ 11.35 $ 4,147,593 367,252 4.53 - 21.28
Last Trade Time Type Quantity Stock Price Currency
17:57:49 formt 100 $ 11.71 USD

Accelerate Diagnostics Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 659.92M 56.36M 31.78M $ 9.30M $ - -1.54 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Accelerate Diagnostics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical AXDX Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week11.2611.7110.2110.99241,3430.454.0%
1 Month12.1612.399.6010.97281,541-0.45-3.7%
3 Months16.5019.119.6014.20325,793-4.79-29.03%
6 Months6.9619.116.8611.70422,9004.7568.25%
1 Year21.0121.284.5312.60341,071-9.30-44.26%
3 Years22.5030.354.5317.60308,334-10.79-47.96%
5 Years18.389930.454.5318.90293,576-6.68-36.32%

Accelerate Diagnostics Description

Accelerate Diagnostics Inc is an in vitro diagnostics company that specializes in rapid diagnostics for infectious pathogens. The firm's core platform, the Accelerate ID/AST System, determines whether live bacterial or fungal cells in a patient sample are susceptible to a particular antibiotic. This test is performed on pathogens that are commonly associated with serious infections and can deliver results more quickly than traditional methods, such as bacterial culturing. The system can analyze a positive blood culture sample in approximately five hours, which is faster than traditional testing techniques.

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.